S. Bridges

发表

Transferrin-like autocrine growth factor, derived from T-lymphoma cells, that inhibits normal T-cell proliferation.

S. Venuta, G. Morrone, M. Turco, 1988, Cancer research.

Highlights from the Fourth Biennial Strategies for an HIV Cure Meeting, 10–12 October 2018, Bethesda, MD, USA

Eric W Refsland, K. Salzwedel, R. Tressler, 2019, Journal of virus eradication.

Serum pseudouridine as a biochemical marker in the development of AKR mouse lymphoma.

T. Russo, F. Cimino, F. Salvatore, 1984, Cancer research.

Whole ricin and recombinant ricin A chain idiotype-specific immunotoxins for therapy of the guinea pig L2C B cell leukemia.

D. Longo, R. Youle, M. Glennie, 1987, Journal of Immunology.

Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A- bearing antigen-presenting cell function

B. Fowlkes, A. Kruisbeek, S. Bridges, 1985, The Journal of experimental medicine.

Humanized immune system mouse models: progress, challenges and opportunities

Todd M. Allen, Brigitte E. Sanders-Beer, K. Palucka, 2019, Nature Immunology.

Suppression of the immune response to immunotoxins with anti-CD4 monoclonal antibodies.

D. Longo, J. Shiloach, R. Youle, 1991, Journal of immunology.

Participation of the humoral immune system in the myeloma-specific transplantation resistance.

S. Bridges, Sandra H. Bridges, 1978, Journal of immunology.

T-cell tumor elimination as a result of T-cell receptor-mediated activation.

D. Longo, J. Ashwell, S. Bridges, 1987, Science.

Recovery of binding activity in reconstituted mouse myeloma proteins.

S. Bridges, J. Little, J. R. Little, 1971, Biochemistry.

In Vivo Antitumor Effects of Anti-I-A Antibodies

D. Longo, S. Bridges, 1987 .

Inhibition of in vivo growth of murine plasmacytoma MOPC-460 by monoclonal anti-idiotypic antibodies directed at distinct idiotypes of the immunoglobulin on the surface of MOPC-460.

S. Bridges, C. Le Guern, C. Gurgo, 1984, Cancer research.

Selective in vivo antitumor effects of monoclonal anti-I-A antibody on B cell lymphoma.

D. Longo, A. Kruisbeek, S. Bridges, 1987, Journal of immunology.

Differences in the properties of cytoplasmic particles and in the expression of virus-specific information in the thymus of normal and lymphomatous AKR mice.

M. Bondurant, S. Bridges, C. Gurgo, 1978, Cancer research.

In vivo treatment of neonatal mice with anti-I-A antibodies interferes with the development of the class I, class II, and Mls-reactive proliferating T cell subset.

D. Longo, A. Kruisbeek, S. Bridges, 1985, Journal of immunology.

Preparation and use of anti-idiotypic antibodies armed with holotoxins or hemitoxins in treatment of B-cell neoplasms.

D. Longo, R. Youle, S. Bridges, 1989, Methods in enzymology.

Human Immunodeficiency Virus and AIDS: Insights from Animal Lentiviruses

N. Sarver, J. Cairns, S. Bridges, 2000, Journal of Virology.

Plasmacytoma spleen colonization: a sensitive, quantitative in vivo assay for idiotype-specific immune suppression of MOPC-315.

R. Lynch, S. Bridges, M. Daley, 1978, Journal of immunological methods.

Myeloma-specific antibodies: studies of their properties and their relationship to tumor immunity.

R. Lynch, S. Bridges, M. Frikke, 1977, Journal of immunology.

Evaluation of monoclonal antibodies to human immunodeficiency virus type 1 primary isolates by neutralization assays: performance criteria for selecting candidate antibodies for clinical trials. AIDS Clinical Trials Group Antibody Selection Working Group.

J. Bradac, S. Bridges, D. Livnat, 1997, The Journal of infectious diseases.

Gene therapy and immune restoration for HIV disease

N. Sarver, S. Bridges, 1995, The Lancet.

T cell tumor cure by T cell receptor-mediated activation requires the development of CD8-dependent host immunity.

D. Longo, S. Bridges, 1990, Journal of immunology.

Humanized immune system mouse models: progress, challenges and opportunities

Todd M. Allen, Brigitte E. Sanders-Beer, K. Palucka, 2019, Nature Immunology.

Conference summary: novel HIV therapies--from discovery to clinical proof of concept.

N. Sarver, R. Black, S. Bridges, 1996, AIDS research and human retroviruses.

Report of the prevention of perinatal HIV type 1 transmission workshop: Conference summary

M. Robb, M. Fowler, P. Fast, 1995 .

The structure of an immunoglobulin light chain fragment in mouse myeloma cells.

S. Bridges, J. Fleischman, 1975, Journal of molecular biology.

SerumPseudouridineas a BiochemicalMarker in the Developmentof AKR Mouse Lymphoma 1

T. Russo, F. Cimino, F. Salvatore, 2006 .

SerumPseudouridine as a Biochemical Markerin the Development of AKR MouseLymphoma1

T. Russo, F. Cimino, F. Salvatore, 1984 .